^
Association details:
Biomarker:No biomarker
Cancer:Soft Tissue Sarcoma
Drug:gemcitabine (DNA synthesis inhibitor) +
dacarbazine (DNA synthesis inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Soft Tissue Sarcoma: Other Recommended Regimens…Gemcitabine and dacarbazine
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Title:

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Excerpt:
Summary of recommendations...The combination of dacarbazine and gemcitabine or gemcitabine/docetaxel is an option in doxorubicin-pretreated patients [II, B].
DOI:
10.1093/annonc/mdy310